Article
A bivalent CMV vaccine formulated with human compatible TLR9 agonist CpG1018 elicits…
medRxiv · 2022 · Dasari, V.; Beckett, K.; Horsefield, S.; Ambalathingal, G.; Khanna, R.
Key facts
| Title | A bivalent CMV vaccine formulated with human compatible TLR9 agonist CpG1018 elicits potent cellular and humoral immunity in HLA expressing mice |
|---|---|
| First author | Dasari, V.; Beckett, K.; Horsefield, S.; Ambalathingal, G.; Khanna, R. |
| Journal | medRxiv |
| Published | Mar 2, 2022 |
| DOI | 10.1101/2022.03.02.482616 |
| Devices mentioned | K042884, K912666 |
| Product codes mentioned | GIA, JRR, KPA, MYA, MXZ, NJT, NKF, LIQ |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1